Cooley, Goodwin Procter and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Arsenal Biosciences on the transaction.Arsenal Biosciences (ArsenalBio) announced raising $325 million in Series C…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
